Showing results (121-130 of 319) with videos related to

Sort By:
Pageof 32
World Journal of Stem Cells|May 1, 2018
NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28BJianbiao Zhou, Jing-Yuan Chooi, Ying Qing Ching, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2019
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and SubgroupsRobert Z Orlowski, Philippe Moreau, Ruben Niesvizky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2013
Direct costs associated with febrile neutropenia in inpatients with hematological diseases in SingaporeYvonne Peijun Zhou, Jing Jin, Ying Ding, et al.
Journal of Medicinal Chemistry|August 20, 2016
Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell LinesEugene Guorong Yang, Nurulhuda Mustafa, Eng Chong Tan, et al.
Molecular Cancer|September 22, 2012
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaJianbiao Zhou, Lip-Lee Cheong, Shaw-Cheng Liu, et al.
The Journal of Clinical Investigation|July 4, 2012
Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stressLiang Chu, Mack Y Su, Leonard B Maggi, et al.
Cancer Research|April 2, 2014
LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemiaPhyllis S Y Chong, Jianbiao Zhou, Lip-Lee Cheong, et al.
Immunotherapy|February 14, 2022
A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cellsXi Zhang, Wei Xia Ang, Zhicheng Du, et al.
Blood Neoplasia|June 24, 2025
Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myelomaEunice Lai, Yu Yang Soon, Ainsley Ryan Yan Bin Lee, et al.
Clinical Hematology International|October 17, 2024
Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review StudyAllison C Y Tso, Wee Joo Chng, Yeow Tee Goh, et al.
Pageof 32